Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NICHD

Vaccine Against Escherichia Coli 0157 Infection

  • Read more about Vaccine Against Escherichia Coli 0157 Infection
Canada
2338093
Filed on 1998-07-20

Vaccine Against Escherichia Coli 0157 Infection Composed of Detoxified LPS Conjugated to Proteins

  • Read more about Vaccine Against Escherichia Coli 0157 Infection Composed of Detoxified LPS Conjugated to Proteins
Brazil
PI9815953-4
Filed on 1998-07-20

Vaccine Against Escherichia Coli 0157 Infection

  • Read more about Vaccine Against Escherichia Coli 0157 Infection
Australia
1998085758
Filed on 1998-07-20

STRUCTURAL MODIFICATION OF 19-NORPROGESTERONE I: 17-a-SUBSTITUTED-11-B-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS NEW ANTIPROGESTATIONAL AGENTS

  • Read more about STRUCTURAL MODIFICATION OF 19-NORPROGESTERONE I: 17-a-SUBSTITUTED-11-B-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS NEW ANTIPROGESTATIONAL AGENTS
Japan
2001-572529
Filed on 2001-03-16

17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as New Antiprogestational Agents

  • Read more about 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as New Antiprogestational Agents
European Patent
01918812.7
Filed on 2001-03-16

17-ALPHA-SUBSTITUTED-11-BETA-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNA 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS ANTIPROGESTATIONAL AGENTS

  • Read more about 17-ALPHA-SUBSTITUTED-11-BETA-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNA 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS ANTIPROGESTATIONAL AGENTS
Canada
2403756
Filed on 2001-03-16

Structural Modification of 19-Norpregnadienedione I: 17-a-Alpha-Substituted-11-Beta-4-Aryl and 21-Substituted 19-Norpregnadienedione as New Antiprogestational Agents

  • Read more about Structural Modification of 19-Norpregnadienedione I: 17-a-Alpha-Substituted-11-Beta-4-Aryl and 21-Substituted 19-Norpregnadienedione as New Antiprogestational Agents
Australia
2001245849
Filed on 2001-03-16

Methods and Compositions for Bisubstrate Inhibitors of Acetyltransferases

  • Read more about Methods and Compositions for Bisubstrate Inhibitors of Acetyltransferases
European Patent
00952645.0
Filed on 2000-08-08

METHODS OF INHIBITING CANCER CELLS WITH ADNF III ANTISENSE OLIGONUCLEOTIDES

  • Read more about METHODS OF INHIBITING CANCER CELLS WITH ADNF III ANTISENSE OLIGONUCLEOTIDES
European Patent
00955282.9
Filed on 2000-07-28

METHOD FOR PREPARING 17ALPHA-ACETOXY-11BETA-(4-N,N-DIMETHYLAMINOPHYL)- 19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES USEFUL IN THE...

  • Read more about METHOD FOR PREPARING 17ALPHA-ACETOXY-11BETA-(4-N,N-DIMETHYLAMINOPHYL)- 19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES USEFUL IN THE...
European Patent
96909749.2
Filed on 1996-03-18

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 128
  • Page 129
  • Page 130
  • Page 131
  • Page 132
  • Page 133
  • Page 134
  • Page 135
  • Page 136
  • …
  • Next page ››
  • Last page Last »
Subscribe to NICHD
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health